Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cyrus Harmon currently holds 29,500 shares of Olema Pharmaceuticals, Inc. (OLMA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cyrus Harmon has been a net seller of OLMA stock. They have purchased $0 and sold $6.1M worth of shares.
Cyrus Harmon's most recent insider trade was on Jun 18, 2026, when they sold 29,500 shares at $0.00 per share.
Cyrus Harmon serves as Executive at Olema Pharmaceuticals, Inc. (OLMA). They have executed 52 insider transactions totaling $6.1M over their tenure at the company.
Cyrus Harmon holds the position of Executive at Olema Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Cyrus Harmon has shown a selling trading pattern, with $0 in total purchases and $6.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cyrus Harmon was on Sep 20, 2021, when they sold $315.6K worth of OLMA shares. This transaction involved 12,000 shares at $26.30 per share.
Cyrus Harmon currently owns 29,500 shares of Olema Pharmaceuticals, Inc. (OLMA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cyrus Harmon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cyrus Harmon has 52 Form 4 filings on record as an insider at Olema Pharmaceuticals, Inc..
Set alerts for Cyrus Harmon and 40,000+ other insiders.